
Biotheus, a Chinese start-up that specializes in the discovery and development of therapeutic biologics in the oncology disease space, announced on Wednesday that it has raised over RMB100 million (US$14.51 million) in a series pre-A round of financing led by Chinese healthcare-focused private equity firm Shiyu Capital. Chinese private equity firm Zhuhai Huaying Investment also […]
Chinese PE Firm Shiyu Capital Leads Over $14M Series Pre-A Round In Biotech Start-Up comes originally from China Money Network. All Rights Reserved.